期刊文献+

子宫平滑肌肉瘤脑转移一例报告及文献复习 被引量:1

原文传递
导出
摘要 平滑肌肉瘤占成人软组织肿瘤发病率的5%~10%,是常见的恶性肿瘤之一。在中枢神经系统中,颅内原发平滑肌肉瘤极其罕见,其病因为免疫缺陷(HIV感染)或全脑放疗所致,主要以转移性病变为主。我们对一子宫平滑肌肉瘤脑转移患者进行治疗,结合文献,对其治疗及预后进行探讨。
出处 《中华神经外科杂志》 CSCD 北大核心 2009年第11期1034-1035,共2页 Chinese Journal of Neurosurgery
  • 相关文献

参考文献5

二级参考文献39

  • 1[1]Sutton GP,Blessing JA,Rosenshein N,et al.Phase Ⅱ trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study).Am J Obstet Gynecol,1989,161(2:309-312
  • 2[2]Sutton G,Blessing J,Barret RJ,et al.Phase Ⅱ trial of ifosfamide and mesna in leiomyosarcoma of the uterus:a Gynecologic Oncology Group study.Am J Obstet Gynecol,1992,166(2:556-559
  • 3[3]Thigpen JT,Blessing JA,Beecham J,et al.Phase Ⅱ trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcoma:a Gynecologic Oncology Group study.J Clin Oncol,1991,9(11:1962-1966
  • 4[4]Omura GA,Major FJ,Blessing JA,et al.A randomized study of adrimycin with or without dimethyl triazinoimidazole carboxamide in advanced uterine sarcomas.Cancer,1983,52(4):626-632
  • 5[5]Miller DS,Blessing JA,Kilgore LC,et al.Phase Ⅱ trial of topotecan in patients with advanced,persistent,or recurrent uterine leiomyosarcoma:a Gynecologic Oncology Group study.Am J Clin Oncol,2000,23(4):355-357
  • 6[6]Curtin JP,Blessing JA,Soper JT,et al.Paclitaxel in the treatment of carcinosarcoma of the uterus:a Gynecologic Oncology Group study.Gynecol Oncol,2001,83(2:268-270
  • 7[7]Gallup DG,Blessing JA,Andersen W,et al.Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus:a Gynecologic Oncology Group study.Gynecol Oncol,2003,89(1:48-51
  • 8[8]Okuno S,Edmonson J,Mahoney M,et al.Phase Ⅱ trial of Gemcitabine in advanced sarcomas.Cancer,2002,94(12:3225-3229
  • 9[9]Hensley ML,Maki R,Venkatraman E,et al.Gemcitabine and docetaxel in patients with unresected leiomyosarcoma:results of a phase Ⅱ trial.J Clin Oncol,2002,20(12:2824-2831
  • 10[10]Pautier P,Genestie C,Fizazi K,et al.Cisplatin-based chemotherapy regimen(DECAV) for uterine sarcomas.Int J Gynecol Cancer,2002,12(6):749-754

共引文献44

同被引文献28

  • 1曹泽毅主编.中华妇产科学[M].北京:人民卫生出版社,2009:383-385.
  • 2Kapp DS, Shin 3Y, Chan JK, Prognostic factors and survival in 1396 patients with uterine leiomyosarcoma: emphasis on impact of lymphadenectomy and oophorectomy [J]. Cancer 2008, 112 : 820.
  • 3Major FJ, Blessing JA, Silverberg SG, et al. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study[J]. Cancer, 1993,71 (4 Suppl) : 1702.
  • 4Emoto M, Iwasaki H, Ishiguro M, et al. Angiogenesis in carcinol sarcomas of the uterus : differences in the microvessel density and expression of vascular endothelial growth factor between the epil thlial and mesenchymal elements[J]. Hum pathol, 1999,30(10): 1232.
  • 5Kido A, Togashi K, Koyama T, et al. Diffusely enlarged uterus: evaluation with MR imaging[J]. Radiographies, 2003,23 : 1423.
  • 6Chander S, Ergun EL. Positron emission tomographic-computed tomographic imaging of a uterine sarcoma[J]. Clin Nucl Med, 2002,28:443.
  • 7Jhang H,Chuang L,Visintainer P,et al. CA125 levels in the pre- operative assessment of advanced-stage uterine cancer[J]. Am J Gyneeo,2003,188(5) :1195.
  • 8Akhan SE, Yavuz E, Tecer A, et al. The expression of K i 67, p53,estrogen and progesterone receptors affecting survival in u- terine leiomyosarcomas. A clinicopathologic study[J]. Gynecol Oncol, 2005,99 : 36.
  • 9D'AngeIo E,Spagnoli LG,Prat J. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diag nosed using the World Health Organization classification system [J]. Hum Pathol,2009,40:1571.
  • 10Giuntoli RI 2nd,Metzinger DS,DiMarco CS,et al. RetrospectiVe reView of 208 patients with leiomyosarcoma of the utems= prog- nostic indicators, surgical management and adjuvant thempy[J]. Gyneeol Oneol, 2003,89 ( 3 ) : 460.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部